![](/img/cover-not-exists.png)
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model
Hasan C. Ugur, Naren Ramakrishna, Lorenzo Bello, Lata G. Menon, Seung-Ki Kim, Peter M. Black, Rona S. CarrollVolume:
83
Language:
english
Pages:
9
DOI:
10.1007/s11060-007-9337-z
Date:
July, 2007
File:
PDF, 423 KB
english, 2007